Bruno Lucidi's Insider Trades & SAST Disclosures
Bruno Lucidi's most recent trade in Atea Pharmaceuticals Inc was a trade of 41,200 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bruno Lucidi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 41,200 | 41,200 | - | - | Stock Option (Right to Buy) | |
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 29,600 | 29,600 | - | - | Restricted Stock Units | |
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 33,150 | 83,150 | - | 0 | Common Stock | |
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 33,150 | 0 | - | - | Restricted Stock Units | |
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 46,750 | 46,750 | - | - | Stock Option (Right to Buy) | |
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 33,150 | 33,150 | - | - | Restricted Stock Units | |
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 61,264 | 61,264 | - | - | Stock Option (Right to Buy) | |
|
Atea Pharmaceuticals Inc
|
Bruno Lucidi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges